Fibroblast growth factor receptor 4 (FGFR4): a targetable regulator of drug resistance in colorectal cancer

The discovery of underlying mechanisms of drug resistance, and the development of novel agents to target these pathways, is a priority for patients with advanced colorectal cancer (CRC). We previously undertook a systems biology approach to design a functional genomic screen and identified fibroblas...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Turkington, R C, Longley, D B, Allen, W L, Stevenson, L, McLaughlin, K, Dunne, P D, Blayney, J K, Salto-Tellez, M, Van Schaeybroeck, S, Johnston, P G
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2014
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3944229/
https://ncbi.nlm.nih.gov/pubmed/24503538
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddis.2014.10
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados